Unsay buot ipasabot sa “Klaro”?
Ang mananap wala magdala sa mutation. Dili kini makapalambo sa sakit ug dili kini ipasa.
Iro Hypomyelinating Polyneuropathy Variant 2 (HMP2)
The DNA test for Hypomyelinating Polyneuropathy Variant 2 (HMP2) in dogs is essential for early diagnosis and breeding decisions. HMP2 is a genetic disorder affecting the nervous system, leading to muscle weakness and coordination issues. By identifying carriers and affected dogs through this test, breeders can prevent passing the condition to future generations. This accurate and reliable DNA test helps maintain the health and vitality of your dog breed. Early detection of HMP2 allows for better management and care of affected dogs. Ensure your dog’s genetic health with the Hypomyelinating Polyneuropathy Variant 2 DNA test today. Protect your canine companion from hereditary neurological disorders with this vital screening tool.
Minubo: HMP2
Gi-analisa nga mutation: MPZ c.434T>C
Kabilin: Autosomal Recessive
Acronym
HMP2
Naobserbahan nga frequency
Klinikal nga kagrabe
Klasipikasyon sa klinika
Mga Sakit sa Neurological
Gi-analisa nga mutation
MPZ c.434T>C
p.(I145T)
p.(I145T)
Pamaagi sa pagpanunod
Autosomal Recessive
Summary sa pagsulay:
Hypomyelinating Polyneuropathy Variant 2 (HMP2) is a genetic disorder affecting dogs, characterized by defective myelin formation in peripheral nerves. This condition leads to muscle weakness, poor coordination, and progressive neurological decline. A DNA test for HMP2 helps identify carriers and affected dogs, enabling responsible breeding decisions. Early diagnosis through genetic testing can improve management and care for affected dogs. Understanding HMP2 is crucial for breeders aiming to reduce the incidence of this debilitating disease.
Anaa gikan sa pakete: Basic
Kini nga pagsulay sa DNA gilakip sugod sa among pakete Basic — ug kabahin usab sa mga pakete Basic, Standard, Advanced, Complete.
Tan-awa ang DNA Test Packs →Pilia ang pack nga labing haum sa imong breeding o estratehiya sa kahimsog sa imong mga hayop.
Overview of Hypomyelinating Polyneuropathy Variant 2 (HMP2)
Hypomyelinating Polyneuropathy Variant 2 (HMP2) is a genetic disorder that affects the peripheral nervous system in dogs. This condition is characterized by a deficiency in the myelin sheath, which is essential for the proper functioning of nerve cells. Myelin, a fatty substance, insulates nerve fibers and facilitates the rapid transmission of electrical signals between the brain and various parts of the body. In HMP2, the lack of adequate myelin leads to a range of neurological symptoms that can significantly impact a dog's quality of life.
Mga Sintomas ug Mga Sintomas sa Klinikal
Dogs with HMP2 may exhibit a variety of clinical signs, often appearing in early life. These symptoms can include muscle weakness, difficulty walking, decreased coordination, and an overall lack of energy. As the condition progresses, affected dogs may show further signs such as muscle atrophy, tremors, and challenges in maintaining balance. The severity and specific manifestations of the disease can vary widely among individual dogs, making it crucial for owners to monitor any changes in their pet's behavior or physical capabilities.
Genetic Basis of HMP2
The underlying cause of Hypomyelinating Polyneuropathy Variant 2 is a mutation in specific genes that are critical for the development and maintenance of myelin. This genetic defect disrupts the normal formation of myelin, leading to the demyelination of nerves. The hereditary nature of HMP2 means that the condition can be passed down through generations, which underscores the importance of genetic testing for dogs that may be at risk.
Diagnosis of HMP2
To confirm a diagnosis of Hypomyelinating Polyneuropathy Variant 2, veterinarians often rely on a combination of clinical evaluations, neurological examinations, and advanced diagnostic techniques. Although a definitive diagnosis may involve genetic testing, clinical signs and a thorough understanding of the dog's health history play crucial roles in identifying the condition. Early diagnosis is vital for managing symptoms and improving the dog's quality of life.
Pagdumala ug Pag-atiman
While there is currently no cure for HMP2, supportive care can help manage the symptoms and enhance the quality of life for affected dogs. This may include physical therapy to improve mobility, nutritional support to maintain strength, and medications to address pain or discomfort. Regular veterinary check-ups are essential to monitor the progression of the disease and adjust treatment plans as necessary.
Panapos
Hypomyelinating Polyneuropathy Variant 2 is a serious genetic condition that impacts the nervous system of dogs, leading to various neurological challenges. Understanding the nature of this disorder, recognizing its symptoms, and providing appropriate care can help affected dogs live more comfortably. Genetic testing plays a crucial role in identifying potential carriers, thereby aiding in responsible breeding practices to minimize the occurrence of HMP2 in future generations.
Giila ang lahi alang sa pagsulay: Hypomyelinating Polyneuropathy Variant 2 (HMP2)
- Golden Retriever
🧬 Interpretation of genotypes HMP2
Genotype
Status
🟡 N/N
Non-carrier - Walay Risgo
🟡 N/HMP2
Tagadala - Walay Risgo
❌ HMP2/HMP2
Naapektuhan - Naa sa Risgo
FAQ: pagsabot sa interpretasyon
Seryoso ba ang usa ka "Carrier"?
Dili. Ang mananap sa kasagaran himsog apan makapasa sa mutation ngadto niini kaliwat.
Komosta kon ang usa ka mananap “Naapektuhan”?
Nagdala kini og duha ka mutated nga kopya. Ang mga klinikal nga timailhan gilauman depende sa ang sakit. Kinahanglan nga dili kini ipanganak.
Ngano nga adunay mga kalainan tali sa lalaki / babaye?
Ang ubang mga sakit nalangkit sa sekso, busa ang ilang ekspresyon magkalahi depende sa sekso sa hayop.
Tagna ang Kaliwat
N/N (dili-tigdala)
N/HMP2 (Tagadala)
HMP2/HMP2 (Naapektuhan)
DNA Test FAQ
Unsay namatikdan niini nga DNA test?
This DNA test detects the mutation associated with Hypomyelinating Polyneuropathy Variant 2 (HMP2) in order to identify clear, carrier, or at-risk animals.
Nganong sulayan ang usa ka breeding animal?
Ang pagsulay sa DNA makatabang sa mga breeder sa pagplano sa mas luwas nga mga pagsanay ug pagpakunhod sa risgo sa pagpasa sa mutation ngadto sa mga anak.
Unsa ang paagi sa pagpanunod niini nga pagsulay?
Ang inheritance mode nga gitaho alang niini nga pagsulay mao ang Autosomal Recessive.
Unsang mutation ang gi-analisa sa kini nga pagsulay?
This test analyses the mutation MPZ c.434T>C.
Kinahanglan ba nga maapektuhan ang usa ka hayop nga tigdala?
Dili kinahanglan. Ang interpretasyon nagdepende sa sumbanan sa kabilin ug sa resulta nga genotype.
Mga pakisayran
Cook Shawna, Hooser Blair N, Williams D Colette, Kortz Gregg, Aleman Monica, Minor Katie, Koziol Jennifer, Friedenberg Steven G, Cullen Jonah N, Shelton G Diane, Ekenstedt Kari J. Canine models of Charcot-Marie-Tooth: MTMR2, MPZ, and SH3TC2 variants in golden retrievers with congenital hypomyelinating polyneuropathy. Neuromuscul Disord. 2023 Aug;33(8):677-691. doi: 10.1016/j.nmd.2023.06.007. Epub 2023 Jun 22.